3Miller M. Current perspectives on the management of hypertriglyceridemia. Am Heart J, 2000,140: 232-240.
4Cole TG, Klotzsch SG, McNamara JR . Measurement of triglyceride concentration. In: Rifai N, Warnick GR, Dominiczak MH, eds. Handbook of lipoprotein testing. Washington : AACC Press, 2000.207-219.
5Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med , 2001 , 47:111-136.
6Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. Clin Chem , 1995,41:1427-1433.
7Holani KK, Miller WG, Waymack PP. Robustness of three triglyceride reagents for matrix effects of proficiency testing . Clin Chem , 1993,39:1126-1128.
8Klotzsch SG , McNamara JR . Triglyceride measurements: A review of methods and interferences. Clin Chem , 1990,36 : 1605-1613.
9Eberly LE, Stamler J, Neaton JD .Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Arch Intern Med,2003,163:1077-1083.
10Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ). JAMA, 2001,285: 2486-2497.
